Brady (BRC) Research & Development

: $65 Mil (TTM As of Jan. 2024)

View and export this data going back to 1984. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Brady's Research & Development for the three months ended in Jan. 2024 was $17 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was $65 Mil.

Brady Research & Development Historical Data

The historical data trend for Brady's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brady Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Research & Development

Get a 7-Day Free Trial

45.17

40.66

44.55

58.55

61.37

Brady Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Research & Development	Get a 7-Day Free Trial															15.38	15.72	16.34	15.70	16.83

Brady Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $65 Mil.

Brady (NYSE:BRC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Brady Research & Development Related Terms

Thank you for viewing the detailed overview of Brady's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Brady (BRC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Brady Corp (NYSE:BRC) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

BRV:Germany

Address

6555 West Good Hope Road, Milwaukee, WI, USA, 53223

Website

https://www.bradyid.com

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labelling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The largest end market is the United States.

Executives

Bentley Curran	officer: VP Chief Information Officer	6555 WEST GOOD HOPE ROAD, MILWAUKEE WI 53223
Brett Wilms	officer: President - EMEA & Australia	6555 W GOOD HOPE ROAD, MILWAUKEE WI 53223
Nancy Lee Gioia	director	6555 WEST GOOD HOPE RD., MILWAUKEE WI 53223
Olivier Bojarski	officer: President, Identification Soln	C/O BELDEN INC., 1 N. BRENTWOOD BOULEVARD, 15TH FLOOR, SAINT LOUIS MO 63105
Frank W Harris	director	244 SUMMER ST POLYMER BLDG 603, AKRON OH 53202
Elizabeth P Pungello	director	6555 WEST GOOD HOPE RD., MILWAUKEE WI 53223
Russell Shaller	director	6555 WEST GOOD HOPE RD, MILWAUKEE WI 53223
Smee Joanne Collins	director	XEROX CORPORATION, 201 MERRITT 7, NORWALK CT 06851
Vineet A Nargolwala	director	529 PLEASANT STREET, MAIL STATION B-1, ATTLEBORO MA 02703
Andrew Gorman	officer: General Counsel&Corp Secretary	6555 WEST GOOD HOPE ROAD, MILWAUKEE WI 53223
Pascal Deman	officer: VP & GM Workplace Safety	6555 WEST GOOD HOPE ROAD, MILWAUKEE WI 53223
Thomas J Felmer	officer: SR VP CFO	6555 WEST GOOD HOPE ROAD, MILWAUKEE WI 53223
Louis T Bolognini	officer: SR VP - GENERAL COUNSEL	P O BOX 9, SUGAR LAND TX 77487
J Michael Nauman	director, officer: President & CEO	C/O MOLEX INCORPORATED, 2222 WELLINGTON COURT, LISLE IL 60532
Bradley C Richardson	director